Drug profile · INN
collagenase clostridium histolyticum
XIAPEX
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
collagenase clostridium histolyticum (XIAPEX) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN collagenase clostridium histolyticum
Brand XIAPEX
Route INJECTION
Formulation SOLUTION
ATC code M09AB02
Frequently asked questions
What is collagenase clostridium histolyticum?
collagenase clostridium histolyticum (XIAPEX) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for collagenase clostridium histolyticum?
XIAPEX is a marketed brand name for collagenase clostridium histolyticum. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of collagenase clostridium histolyticum?
collagenase clostridium histolyticum has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.